5002092026-04-012026-06-305002092026-06-305002092026-04-012026-06-30CompositionOfBoardOfDirectors15002092026-06-30CompositionOfBoardOfDirectors15002092026-04-012026-06-30CompositionOfBoardOfDirectors25002092026-06-30CompositionOfBoardOfDirectors25002092026-04-012026-06-30CompositionOfBoardOfDirectors35002092026-06-30CompositionOfBoardOfDirectors35002092026-04-012026-06-30CompositionOfBoardOfDirectors45002092026-06-30CompositionOfBoardOfDirectors45002092026-04-012026-06-30CompositionOfBoardOfDirectors55002092026-06-30CompositionOfBoardOfDirectors55002092026-04-012026-06-30CompositionOfBoardOfDirectors65002092026-06-30CompositionOfBoardOfDirectors65002092026-04-012026-06-30CompositionOfBoardOfDirectors75002092026-06-30CompositionOfBoardOfDirectors75002092026-04-012026-06-30CompositionOfBoardOfDirectors85002092026-06-30CompositionOfBoardOfDirectors85002092026-04-012026-06-30CompositionOfBoardOfDirectors95002092026-06-30CompositionOfBoardOfDirectors95002092026-04-012026-06-30CompositionOfBoardOfDirectors105002092026-06-30CompositionOfBoardOfDirectors105002092026-04-012026-06-30CompositionOfCommittees145002092026-06-30CompositionOfCommittees145002092026-04-012026-06-30CompositionOfCommittees155002092026-06-30CompositionOfCommittees155002092026-04-012026-06-30CompositionOfCommittees165002092026-06-30CompositionOfCommittees165002092026-04-012026-06-30CompositionOfCommittees175002092026-06-30CompositionOfCommittees175002092026-04-012026-06-30CompositionOfCommittees415002092026-06-30CompositionOfCommittees415002092026-04-012026-06-30CompositionOfCommittees425002092026-06-30CompositionOfCommittees425002092026-04-012026-06-30CompositionOfCommittees435002092026-06-30CompositionOfCommittees435002092026-04-012026-06-30CompositionOfCommittees445002092026-06-30CompositionOfCommittees445002092026-04-012026-06-30CompositionOfCommittees685002092026-06-30CompositionOfCommittees685002092026-04-012026-06-30CompositionOfCommittees695002092026-06-30CompositionOfCommittees695002092026-04-012026-06-30CompositionOfCommittees705002092026-06-30CompositionOfCommittees705002092026-04-012026-06-30CompositionOfCommittees715002092026-06-30CompositionOfCommittees715002092026-04-012026-06-30CompositionOfCommittees955002092026-06-30CompositionOfCommittees955002092026-04-012026-06-30CompositionOfCommittees965002092026-06-30CompositionOfCommittees965002092026-04-012026-06-30CompositionOfCommittees975002092026-06-30CompositionOfCommittees975002092026-04-012026-06-30CompositionOfCommittees985002092026-06-30CompositionOfCommittees985002092026-04-012026-06-30CompositionOfCommittees995002092026-06-30CompositionOfCommittees995002092026-04-012026-06-30CompositionOfCommittees1005002092026-06-30CompositionOfCommittees1005002092026-04-012026-06-30CompositionOfCommittees1015002092026-06-30CompositionOfCommittees1015002092026-04-012026-06-30CompositionOfCommittees1225002092026-06-30CompositionOfCommittees1225002092026-04-012026-06-30CompositionOfCommittees1235002092026-06-30CompositionOfCommittees1235002092026-04-012026-06-30CompositionOfCommittees1245002092026-06-30CompositionOfCommittees1245002092026-04-012026-06-30CompositionOfCommittees1495002092026-04-012026-06-30CompositionOfCommittees1505002092026-04-012026-06-30CompositionOfCommittees1515002092026-06-30MeetingOfBoardOfDirectors15002092026-04-012026-06-30MeetingOfBoardOfDirectors15002092026-06-30MeetingOfBoardOfDirectors25002092026-04-012026-06-30MeetingOfBoardOfDirectors25002092026-06-30MeetingOfBoardOfDirectors35002092026-04-012026-06-30MeetingOfBoardOfDirectors35002092026-06-30MeetingOfBoardOfDirectors45002092026-04-012026-06-30MeetingOfBoardOfDirectors45002092026-04-012026-06-30MeetingOfCommittees15002092026-06-30MeetingOfCommittees15002092026-04-012026-06-30MeetingOfCommittees25002092026-06-30MeetingOfCommittees25002092026-04-012026-06-30MeetingOfCommittees35002092026-06-30MeetingOfCommittees35002092026-04-012026-06-30MeetingOfCommittees45002092026-06-30MeetingOfCommittees45002092026-04-012026-06-30MeetingOfCommittees55002092026-06-30MeetingOfCommittees55002092026-04-012026-06-30MeetingOfCommittees65002092026-06-30MeetingOfCommittees65002092026-04-012026-06-30MeetingOfCommittees75002092026-06-30MeetingOfCommittees75002092026-04-012026-06-30MeetingOfCommittees85002092026-06-30MeetingOfCommittees85002092026-04-012026-06-30MeetingOfCommittees95002092026-06-30MeetingOfCommittees95002092026-04-012026-06-30MeetingOfCommittees105002092026-06-30MeetingOfCommittees105002092026-04-012026-06-30MeetingOfCommittees115002092026-06-30MeetingOfCommittees115002092026-04-012026-06-30MeetingOfCommittees125002092026-06-30MeetingOfCommittees125002092026-04-012026-06-30MeetingOfCommittees135002092026-06-30MeetingOfCommittees135002092026-04-012026-06-30MeetingOfCommittees145002092026-06-30MeetingOfCommittees145002092026-03-315002092026-06-30UnlistedCompanyDomain15002092026-04-012026-06-30UnlistedCompanyDomain15002092026-03-31UnlistedCompanyDomain15002092026-06-30UnlistedCompanyDomain25002092026-04-012026-06-30UnlistedCompanyDomain25002092026-03-31UnlistedCompanyDomain25002092026-06-30UnlistedCompanyDomain35002092026-04-012026-06-30UnlistedCompanyDomain35002092026-03-31UnlistedCompanyDomain35002092026-06-30UnlistedCompanyDomain45002092026-04-012026-06-30UnlistedCompanyDomain45002092026-03-31UnlistedCompanyDomain45002092026-06-30UnlistedCompanyDomain55002092026-04-012026-06-30UnlistedCompanyDomain55002092026-03-31UnlistedCompanyDomain55002092026-06-30UnlistedCompanyDomain65002092026-04-012026-06-30UnlistedCompanyDomain65002092026-03-31UnlistedCompanyDomain65002092026-06-30ImpositionOfFineOrPenaltyDomain15002092026-06-30ImpositionOfFineOrPenaltyDomain25002092026-06-30ImpositionOfFineOrPenaltyDomain35002092026-06-30ImpositionOfFineOrPenaltyDomain45002092026-06-30ImpositionOfFineOrPenaltyDomain55002092026-06-30ImpositionOfFineOrPenaltyDomain65002092026-06-30ImpositionOfFineOrPenaltyDomain75002092026-06-30ImpositionOfFineOrPenaltyDomain85002092026-06-30ImpositionOfFineOrPenaltyDomain95002092026-06-30ImpositionOfFineOrPenaltyDomain105002092026-06-30ImpositionOfFineOrPenaltyDomain115002092026-06-30ImpositionOfFineOrPenaltyDomain125002092026-06-30ImpositionOfFineOrPenaltyDomain13xbrli:pure500209INFYNAINE009A01021INFOSYS LIMITED2026-04-012027-03-31Quarterly2026-06-30EquitytruetruetruetruefalseNo such eventtrueTop 100 listed entitiestrueinfosysltdOriginalNitin Paranjpe was appointed as Vice Chairman of the Board effective April 30, 2026.truefalseMrNandan Nilekani******00041245Non-Executive - Non Independent DirectorChairperson related to Promoter1955-06-02falseActiveNA2017-08-241000MrSalil Parekh******01876159Executive DirectorNot ApplicableCEO-MD1964-06-05falseActiveNA2018-01-022022-07-011000MrD. Sundaram******00016304Non-Executive - Independent DirectorNot Applicable1953-04-16falseActiveNA2017-07-142022-07-141083283MrMichael Nelson Gibbs******08177291Non-Executive - Independent DirectorNot Applicable1957-11-08falseActiveNA2018-07-132021-07-13961121PAN is not applicable as the director is a Foreign directorMrBobby Kanubhai Parikh******00019437Non-Executive - Independent DirectorNot Applicable1964-04-30falseActiveNA2020-07-152023-07-15724373MsChitra Nayak******09101763Non-Executive - Independent DirectorNot Applicable1963-04-09falseActiveNA2021-03-252024-03-25631110MrGovind Iyer******00169343Non-Executive - Independent DirectorNot Applicable1962-09-22falseActiveNA2023-01-122023-01-12421100MsHelene Auriol Potier******10166891Non-Executive - Independent DirectorNot Applicable1962-11-26falseActiveNA2023-05-262026-05-26371100PAN is not applicable as the director is a Foreign directorMrNitin Paranjpe******00045204Non-Executive - Independent DirectorNot Applicable1963-03-04falseActiveNA2024-01-012024-01-01302110MsDiane Enberg Jurgens******11585200Non-Executive - Independent DirectorNot Applicable1962-09-21falseActiveNA2026-04-222026-04-2231100PAN is not applicable as the director is a Foreign directortruetruetruetruetrueAudit Committee00019437Bobby Kanubhai ParikhNon-Executive - Independent DirectorChairperson2020-07-16Bobby Kanubhai Parikh was appointed as a Member of Audit committee effective 16-Jul-2020 and later became the chairperson of the committee effective 23-Mar-2023.Audit Committee00016304D. SundaramNon-Executive - Independent DirectorMember2017-07-14Audit Committee08177291Michael Nelson GibbsNon-Executive - Independent DirectorMember2020-02-04Audit Committee00045204Nitin ParanjpeNon-Executive - Independent DirectorMember2025-04-16Nomination and remuneration committee00016304D. SundaramNon-Executive - Independent DirectorChairperson2017-07-14D. Sundaram was appointed as a member of Nomination and Remuneration Committee effective 14-Jul-2017 and later became the chairperson of the committee effective 23-Mar-2023Nomination and remuneration committee08177291Michael Nelson GibbsNon-Executive - Independent DirectorMember2020-04-21Nomination and remuneration committee00169343Govind IyerNon-Executive - Independent DirectorMember2023-01-13Nomination and remuneration committee00045204Nitin ParanjpeNon-Executive - Independent DirectorMember2024-01-01Stakeholders Relationship Committee08177291Michael Nelson GibbsNon-Executive - Independent DirectorChairperson2023-03-23Michael Gibbs was appointed as member and Chairperson of Stakeholders Relationship Committee effective 23-Mar-2023Stakeholders Relationship Committee00016304D. SundaramNon-Executive - Independent DirectorMember2020-04-21Stakeholders Relationship Committee00019437Bobby Kanubhai ParikhNon-Executive - Independent DirectorMember2021-01-14Stakeholders Relationship Committee09101763Chitra NayakNon-Executive - Independent DirectorMember2021-03-25Risk Management Committee00016304D. SundaramNon-Executive - Independent DirectorChairperson2017-07-14D. Sundaram was appointed as a member of Risk Management Committee effective 14-Jul-2017 and later became the chairperson of the committee effective 21-Apr-2020.Risk Management Committee08177291Michael Nelson GibbsNon-Executive - Independent DirectorMember2018-07-13Risk Management Committee00019437Bobby Kanubhai ParikhNon-Executive - Independent DirectorMember2020-07-16Risk Management Committee09101763Chitra NayakNon-Executive - Independent DirectorMember2021-03-25Risk Management Committee00169343Govind IyerNon-Executive - Independent DirectorMember2023-01-13Risk Management Committee10166891Helene Auriol PotierNon-Executive - Independent DirectorMember2023-06-17Risk Management Committee00045204Nitin ParanjpeNon-Executive - Independent DirectorMember2024-01-01Corporate Social Responsibility Committee00169343Govind IyerNon-Executive - Independent DirectorChairperson2023-01-13Govind Iyer was appointed as a member of Corporate Social Responsibility committee effective 13-Jan-2023 and later became the chairperson of the committee effective 23-Mar-2023.Corporate Social Responsibility Committee09101763Chitra NayakNon-Executive - Independent DirectorMember2021-03-25Corporate Social Responsibility Committee08177291Michael Nelson GibbsNon-Executive - Independent DirectorMember2023-04-20Other Committee09101763Chitra NayakEnvironmental, Social and Governance CommitteeNon-Executive - Independent DirectorChairpersonChitra Nayak was appointed as a member of Environmental, Social and Governance committee effective 14-Apr-2021 and later became the chairperson of the committee effective 14-Apr-2022Other Committee00169343Govind IyerEnvironmental, Social and Governance CommitteeNon-Executive - Independent DirectorMemberOther Committee10166891Helene Auriol PotierEnvironmental, Social and Governance CommitteeNon-Executive - Independent DirectorMemberThe Board meeting concluded on April 23, 2026, was held over two days, i.e. April 22, 2026 and April 23, 2026.2026-01-14true9972026-03-2569true9862026-04-2328true101082026-04-306true10108Note 1. The Audit Committee meeting concluded on April 23, 2026, was held over two days, i.e. April 22, 2026 and April 23, 2026. 2. The Nomination & Remuneration Committee meeting concluded on April 23, 2026, was held over two days, i.e. April 22, 2026 and April 23, 2026.Audit Committee2026-01-14true4440Audit Committee2026-03-2569true4440Audit Committee2026-04-2328true4440Nomination and remuneration committee2026-01-14true4440Nomination and remuneration committee2026-04-2398true4440Nomination and remuneration committee2026-04-306true4440Risk Management Committee2026-01-08true7770Risk Management Committee2026-04-15true6660Stakeholders Relationship Committee2026-01-07true4440Stakeholders Relationship Committee2026-04-16true4440Corporate Social Responsibility Committee2026-01-08true3330Corporate Social Responsibility Committee2026-04-16true3330Other Committee2026-01-07Environmental Social and Governance Committeetrue3330Other Committee2026-04-16Environmental Social and Governance Committeetrue3330truetruetruetrueYestruetruetrueA.G.S ManikanthaCompany Secretary and Compliance OfficerfalseA.G.S ManikanthaCompany Secretary and Compliance OfficerBengaluru2026-07-23131320-1Note: Infosys recent investments as part of Infosys Innovation Fund: 1. Aerchain (https://aerchain.io/), AI-driven sourcing & procurement startup. Enterprises are unlocking AI value to build smarter sourcing & procurement function. Infosys is at the forefront, bringing AI-powered deeptech solutions to forward-thinking organizations across industries to create a more resilient, informed, and strategic capabilities that gives global corporations an edge in the market. Infosys Innovation Funds investment in Aerchain brings the power of Infosys ecosystem to co-create next-gen solutions making sourcing seamless, data-driven, and future ready. Infosys will transform organizations to accelerate AI-powered value creation and redefine procurement excellence, together with Aerchain. *Agreements were signed in the preceding quarter (25-03-2026); and the corresponding shares were received during the current quarter. 2. 4baseCare (www.4basecare.com), AI powered precision oncology startup. Personalized treatment based on advanced genomic and comprehensive clinical information can enhance cancer-outcomes significantly. The population specific datasets powered by tech-driven AI and Analytics solutions has immense potential to improve cancer diagnosis, treatment, drug discovery and development across Healthcare and Life Sciences ecosystem. 4baseCare develops cutting-edge precision oncology solutions, using advanced genomics and next-gen digital health technology, to personalize patient care in oncology. 4baseCare has developed a unique set of comprehensive genomic panels which allows oncologists to choose the optimal targeted therapy for their patients. 4baseCare is focused on advanced analytics and AI to enhance data-driven treatment recommendations, while expanding the presence across Asia and the Middle East. Infosys Innovation Funds follow-on investment (invested initially in Dec 2024) further strengthens co-creation of next-generation solutions bringing the power of innovation to help Infosys clients across Healthcare and Life Sciences industry. 3. Team8 (https://team8.vc), a global VC firm investing in startups across AI, Cyber Security, Software, Fintech and Digital Health. Infosys commits to invest as a Limited Partner in Team8 as part of Infosys Innovation Fund. Team8 is an early-stage VC fund focused on AI, Cyber Security, Software, Fintech and Digital Health. Backed by a team of serial entrepreneurs, industry leaders and domain experts building a strong system from incubation to investments, Team8 brings corporate partners and startups together to solve most pressing problems with structured partnership programs. Infosys Innovation Fund to partner with Team8s ecosystem and startups to complement Infosys capabilities, and jointly co-create next-generation solutions bringing the power of AI, Cyber Security to help Infosys clients navigate their business transformation. 4. Indivi (https://indivi.io), Switzerland based TechBio startup for neuroscience drug development. Neuroscience has an R&D constraint as the probability of technical and regulatory success is exceptionally low. The ability to measure impact of treatment in a slow progressing and heterogeneous neuroscience disease makes effect detection of the treatment extremely challenging. At the same time, a global epidemic of age-related neuroscience diseases is on a significant rise globally, resulting in pressure on the healthcare systems. Life Sciences companies are investing billions in R&D and clinical trials. The convergence of technological progress (sensor, radiomics, AI/ML, compute, quantum, sequencing) and data creates an opportunity to transform medicine development (patient-centric self-measurement, deep phenotyping of disease, tech-derived biomarkers/endpoints, AI-based companion diagnostics and predictive maintenance, reverse translational discovery). Indivi is a digital bio-marker platform specialist enhancing the success rate drug development in neuroscience. Infosys Innovation Funds investment in Indivi brings the power of Infosys ecosystem to co-create next-gen solutions to unlock value for clients across Healthcare and Life Sciences industry. 5 NinjaTech AI (www.ninjatech.ai), US based personal Agentic AI startup. AI has potential to unlock significant opportunities for enterprises. However, evolving AI capabilities and enterprise needs require effective execution. NinjaTechs personal agentic AI is autonomous, self-evolving, and interacts with other agentic AI and humans. Infosys Innovation Funds investment brings the power of client and business context in amplifying the Human + AI model in AI execution to unlock business value. #Investment is in Simple Agreement for Future Equity (SAFE), ownership % will be determined post conversion. 6 GalaxEye (https://galaxeye.space), SpaceTech startup. SpaceTech is a frontier technology with potential to unlock significant value to businesses globally and create high impact solutions at scale. GalaxEye, builds multi-sensor (Synthetic Aperture Radar + Multi Spectral Imaging) satellites and synchronization platform generating comprehensive all-weather, high-resolution and intuitive datasets. Infosys Innovation Funds follow-on investment (invested initially in 2024) in GalaxEye further strengthens co-creation of next-generation solutions bringing the power of AI and SpaceTech innovation to help clients navigate their business transformation. Agillos E-commerce Private Limited (Aerchain)2026-04-0700.05310.05314baseCare Precision Healthcare Private Limited2026-04-130.04050.02240.0629Team8 Capital III, L.P.2026-04-1300.01320.0132Indivi AG2026-05-1200.01570.0157NinjaTech AI, Inc.2026-06-01000GalaxEye Space Solutions Private Limited2026-06-100.04550.02930.0748Pennsylvania Department of Revenue, USAOrder passed/ action taken. Penalty – USD 1,791.332026-04-01Penalty due to amendment of returns filed for the past quarters.None, there is no material impact on financials, operations or other activities of the Company.Ministry of CommerceOrder passed/ action taken. Penalty – SAR 12,0002026-04-06Penalty for late lodgment of financial statement for CY 2023None, there is no material impact on financials, operations or other activities of the Company.State of Delaware, USAOrder passed/ action taken. Penalty – USD 48.522026-04-18Notice pertaining to withholding filing for the period ending 31st December 2024None, there is no material impact on financials, operations or other activities of the Company.Georgia Department of RevenueOrder passed/ action taken. Penalty – USD 502026-04-27Penalty pertaining to withholding payroll taxNone, there is no material impact on financials, operations or other activities of the Company.Inland Revenue Department, Hong KongOrder passed/ action taken. Penalty – HKD 66812026-05-04Surcharge notice for overdue taxNone, there is no material impact on financials, operations or other activities of the Company.Department of Labor and Workforce Development – State of New JerseyOrder passed/ action taken. Penalty – USD 282.732026-05-08Penalty pertaining to tax to be paid for Q2FY24, Q3FY24,Q3FY25 and Q4FY25None, there is no material impact on financials, operations or other activities of the Company.City of Birmingham, Department of FinanceOrder passed/ action taken. Penalty – USD 183.492026-05-12Penalty levied due to late payment of local taxesNone, there is no material impact on financials, operations or other activities of the Company.Employment Security Department, Washington State, USAOrder passed/ action taken. Penalty – USD 2502026-05-14Penalty due to missing hours and SOC codes in Unemployment Tax and Wage report for Q1FY26None, there is no material impact on financials, operations or other activities of the Company.Michigan Department of TreasuryOrder passed/ action taken. Penalty – USD 24,348.392026-05-27Penalty due to alleged underpayment of state withholding tax for Q12026None, there is no material impact on financials, operations or other activities of the Company.Government of the District of Columbia,Department of Employment ServicesOrder passed/ action taken. Penalty – USD 1002026-06-02Notice received for Late Payment Penalty related to Outstanding Contribution and Wage Report for Tax Period January 2026None, there is no material impact on financials, operations or other activities of the Company.Georgia Department of RevenueOrder passed/ action taken. Penalty – USD 602026-06-11Penalty pertaining to tax liability for Q4FY25None, there is no material impact on financials, operations or other activities of the Company.Department of Finance, DenverOrder passed/ action taken. Penalty – USD 124.312026-06-17Penalty due to alleged underpayment of taxNone, there is no material impact on financials, operations or other activities of the Company.Mauritius Revenue AuthorityOrder passed/ action taken. Penalty – MUR 1,170,9752026-06-29Penalty due to alleged short payment of tax for FY2023None, there is no material impact on financials, operations or other activities of the Company.